Stock

Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports

(Reuters) -President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer (NYSE:PFE) and Eli Lilly (NYSE:LLY) as well as industry lobbying group PhRMA on Wednesday night, Axios reported on Thursday.

Anti-vaccine activist Robert F. Kennedy Jr., Trump’s pick to lead the United States’ top health agency, was also present at the meeting, according to the report.

A PhRMA spokesperson confirmed that its president and CEO, Stephen Ubl, was present at the dinner, but declined to share any other details.

Eli Lilly and Pfizer did not immediately respond to Reuters’ requests for comment.

Trump and the company executives discussed how the public and private sectors can collaborate on finding cures for cancer, among other topics, at the meeting, which took place at Mar-a-Lago, according to the report.

Mar-a-Lago is the Florida mansion and private club that Trump calls home.

Trump’s incoming chief of staff, Susie Wiles, also attended the meeting, the report added.

This post appeared first on investing.com

You May Also Like

Economy

A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

Investing

Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

Editor's Pick

Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

Latest News

A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 balanceandcharge.com

Exit mobile version